Introduction: Semaglutide – 5MG – CARTRIDGE
Laboratory: Pharmaqo
Form: injection
Molecule:GLP-1 RA (Semaglutide)
Concentration: 5mg/vial
Package: 1 cartridge x 5 mg
Recommended dosage: 0.25 – 2.5 mg per Week
Pharmaqo Labs, Semaglutide (GLP-1 RA) 5mg/vial
Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.
It is used as an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.
It reduces food intake by lowering appetite and slowing down digestion in the stomach, helping to reduce body fat.
Its half-life in the blood is about 7 days.
Dosages may vary between users, it’s recommended to start with a low dose and titrate until you reach and maintain the desired effects, dosages can range from 0.25 to 2.5 mg per week.
| Packaging |
5mg CARTRIDGE |
|---|---|
| Strength |
5mg |
Related products
Belzempic EZUSE – Semaglutide – 2mg – Prefilled Pen
-
Introduction: Semaglutide 2mg Prefilled Pen
-
Laboratory: Anabolic Health Standard
-
Form: Prefilled Liquid Pen Device
-
Molecule: Semaglutide (GLP-1 Receptor Agonist)
-
Concentration: 2mg active liquid solution / pen
-
Package: 1 prefilled pen device
-
Purity: >98% (HPLC Certified)
-
Administration Route: Subcutaneous Injection
-
Recommended Dosage: 0.25mg – 1mg / week (titrated gradually under research protocols)
